Oncology · Phase III

Top sponsors

• AstraZeneca 75 programs
• Chinese Academy of 70 programs
• HOFFMANN-LA ROCHE 68 programs
• MSD Merck Sharp 56 programs
• First People's Hospital 53 programs
• Ningbo Cancer Hospital 44 programs
• United Therapeutics Europe 43 programs
• Anaxis Pharma 37 programs
• AstraZeneca 37 programs
• Novartis India 32 programs
• George Institute for 29 programs
• Takeda 28 programs

1. Durvalumab

   AstraZeneca

   Muscle Invasive Bladder Cancer

   phase 3 · small molecule · active

   1 trial →

2. Durvalumab

   AstraZeneca

   Locally Advanced Cervical Cancer

   phase 3 · mab · completed

   1 trial →

3. Durvalumab

   AstraZeneca

   Hepatocellular Carcinoma

   phase 3 · small molecule · active

   2 trials →

4. Durvalumab

   AstraZeneca

   Carcinoma, Non-Small-Cell Lung

   phase 3 · small molecule · active

   1 trial →

5. Durvalumab

   AstraZeneca

   Cancer

   phase 3 · small molecule · active

   1 trial →

6. Durvalumab

   AstraZeneca

   Advanced Hepatocellular Carcinoma

   phase 3 · small molecule · active

   1 trial →

7. Durvalumab + SoC chemotherapy

   AstraZeneca

   Carcinoma, Non-Small-Cell Lung

   phase 3 · small molecule · completed

   1 trial →

8. E7777 9 mcg/kg

   CITIUS ONCOLOGY, INC.

   Persistent or Recurrent Cutaneous T-Cell Lymphoma

   phase 3 · small molecule · completed

   1 trial →

9. EADM

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Carcinoma, Hepatocellular

   phase 3 · small molecule · active

   1 trial →

10. EFC10261

    Regeneron UK Limited

    Carcinoma

    phase 3 · small molecule · completed

    1 trial →

11. EFC10547

    Regeneron UK Limited

    Pancreatic Neoplasm

    phase 3 · small molecule · terminated

    1 trial →

12. EFC12522

    Sanofi-aventis Healthcare Pty Ltd

    Cancer

    phase 3 · small molecule · active

    1 trial →

13. EFC15858

    Sanofi-aventis Healthcare Pty Ltd

    Non-small cell lung cancer metastatic

    phase 3 · other · active

    1 trial →

14. EFC15951

    Sanofi-aventis Healthcare Pty Ltd

    Cancer - Plasma cell myeloma recurrent

    phase 3 · small molecule · active

    1 trial →

15. EFC6125

    Regeneron UK Limited

    Ovarian Neoplasms

    phase 3 · small molecule · completed

    2 trials →

16. EIK1001

    Eikon Therapeutics

    Non Small Cell Lung Cancer (Squamous or Non Squamous)

    phase 3 · small molecule · active

    1 trial →

17. EIK1001

    Eikon Therapeutics

    Advanced Melanoma

    phase 3 · small molecule · active

    1 trial →

18. EIK1001-006

    Eikon Therapeutics

    Advanced Melanoma

    phase 3 · small molecule · active

    1 trial →

19. EMERALD-1

    AstraZeneca AB

    Locoregional Hepatocellular Carcinoma (HCC)

    phase 3 · small molecule · active

    1 trial →

20. ENCITJ-GC01

    Eastern Hepatobiliary Surgery Hospital

    Gastric Cancer

    phase 3 · small molecule · terminated

    1 trial →

21. ENGIC 06 FRUQUITAS

    CERO THERAPEUTICS HOLDINGS, INC.

    metastatic oeso-gastric adenocarcinoma

    phase 3 · small molecule · active

    1 trial →

22. EORTC-2238-GUCG

    Ningbo Cancer Hospital

    Metastatic hormone naïve prostate cancer (mHNPC)

    phase 3 · small molecule · active

    1 trial →

23. ERYTHROPOIETIN , Elritercept

    Takeda

    Myelodysplastic neoplasms/syndromes (MDS)

    phase 3 · small molecule · active

    1 trial →

24. ETOP25-23 ADOPT-lung

    Partner Therapeutics Limited

    Stage IIB-IIIB (N2) resectable non small cell lung cancer

    phase 3 · small molecule · active

    1 trial →

25. ETOPOSIDE - Usual

    Lxo Ireland Designated Activity Company

    Small Cell Lung Cancer

    phase 3 · small molecule · active

    1 trial →

26. Elective nodal irradiation (ENI)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Esophageal Squamous Cell Carcinoma

    phase 3 · other · active

    1 trial →

27. Endoscopic submucosal dissection

    United Therapeutics Europe Ltd

    Colorectal Neoplasms

    phase 3 · other · active

    1 trial →

28. Endoscopic submucosal dissection

    Chinese University of Hong Kong

    Colorectal Neoplasms

    phase 3 · other · active

    1 trial →

29. Endostar

    The First People's Hospital of Lianyungang

    Nasopharyngeal Carcinoma

    phase 3 · small molecule · active

    1 trial →

30. Enzalutamide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Metastatic Hormone Sensitive Prostate Cancer

    phase 3 · small molecule · active

    1 trial →

31. Epinephrine

    Chinese University of Hong Kong

    Gastric Neoplasm

    phase 3 · small molecule · completed

    1 trial →

32. Epirubicin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    phase 3 · small molecule · active

    1 trial →

33. Eribulin Mesylate

    United Therapeutics Europe Ltd

    Breast Adenocarcinoma

    phase 3 · small molecule · on hold

    1 trial →

34. EstroTep 500 MBq/mL, solution injectable

    The George Institute

    Women with ER+ HER2- metastatic breast cancer who progressed on first line therapy with CDK4/6 inhibitor and aromatase inhibitor

    phase 3 · small molecule · active

    1 trial →

35. Etoposide

    The First People's Hospital of Lianyungang

    Non-Hodgkin's Lymphoma

    phase 3 · small molecule · active

    1 trial →

36. Everolimus

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Prostate Cancer

    phase 3 · small molecule · active

    1 trial →

37. Evorpacept (ALX148)

    ALX ONCOLOGY HOLDINGS INC

    Gastric Cancer

    phase 3 · small molecule · active

    1 trial →

38. FE 999326

    Ferring Pharmaceuticals

    Bladder Cancer

    phase 3 · small molecule · active

    1 trial →

39. FIL_FOLL19

    Fondazione Telethon ETS

    Follicular Lymphoma

    phase 3 · small molecule · active

    1 trial →

40. FIL_Renoir12

    Fondazione Telethon ETS

    Follicular lymphoma

    phase 3 · small molecule · active

    1 trial →

41. FKB238 (bevacizumab)

    Centus Biotherapeutics Europe Limited

    Carcinoma, Non-Small-Cell Lung

    phase 3 · small molecule · completed

    1 trial →

42. FLUOROURACIL for Rectal cancer

    Disc Medicine

    Rectal cancer

    phase 3 · small molecule · active

    1 trial →

43. FM-17-B01

    Fondazione Telethon ETS

    Invasive Breast Cancer

    phase 3 · small molecule · active

    1 trial →

44. FUNGEMAX

    CERO THERAPEUTICS HOLDINGS, INC.

    Metastatic pancreatic cancer

    phase 3 · small molecule · active

    1 trial →

45. FURMO-006

    ArriVent BioPharma

    Advanced or Metastatic Non-Small-Cell Lung Cancer With Epidermal Growth Factor Receptor P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

    phase 3 · small molecule · active

    1 trial →

46. FUROSEMIDE , DULOXETINE

    Ningbo Cancer Hospital

    ER positive HER2 negative breast cancer stages I-II

    phase 3 · small molecule · active

    1 trial →

47. Faceptor

    Biotech Pharmaceutical Co.,

    Breast Cancer Metastatic

    phase 3 · small molecule · completed

    2 trials →

48. Farletuzumab

    United Therapeutics Europe Ltd

    Ovarian Cancer

    phase 3 · small molecule · terminated

    1 trial →

Frequently asked questions